Public Employees Retirement System of Ohio Makes New $35,000 Investment in HUTCHMED (China) Limited (NASDAQ:HCM)

Public Employees Retirement System of Ohio purchased a new stake in HUTCHMED (China) Limited (NASDAQ:HCM) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 1,811 shares of the company’s stock, valued at approximately $35,000.

Several other large investors also recently made changes to their positions in HCM. Rhumbline Advisers grew its holdings in shares of HUTCHMED by 8.1% during the second quarter. Rhumbline Advisers now owns 7,553 shares of the company’s stock worth $129,000 after buying an additional 564 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of HUTCHMED by 74.8% during the 2nd quarter. Renaissance Technologies LLC now owns 131,300 shares of the company’s stock worth $2,248,000 after acquiring an additional 56,200 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in shares of HUTCHMED by 9.7% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 13,216 shares of the company’s stock valued at $226,000 after purchasing an additional 1,168 shares during the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of HUTCHMED in the second quarter worth $213,000. Finally, Point72 Asset Management L.P. acquired a new position in HUTCHMED during the second quarter worth $279,000. Institutional investors own 8.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of HUTCHMED from a “buy” rating to a “hold” rating in a research note on Monday, November 18th.

HUTCHMED Stock Down 2.1 %

HUTCHMED stock opened at $14.31 on Monday. HUTCHMED has a fifty-two week low of $11.93 and a fifty-two week high of $21.92. The company’s 50-day moving average is $17.86 and its 200-day moving average is $18.11. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.68 and a current ratio of 2.81.

About HUTCHMED

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.